Generic Drug Maker Gets Chapter 11 OK

Law360 (July 17, 2006, 12:00 AM EDT) -- Able Laboratories, Inc., a former generic pharmaceutical developer, can follow through on its Chapter 11 plans after a bankruptcy judge in New Jersey signed off on its plan to pay off creditors and shutter its doors forever.

The company sold off its assets last year to India’s Sun Pharmaceutical Industries Ltd. to help pay off its creditors. Able will pay back unsecured creditors 27% on their claims with cash from the sale.

Judge Raymond T. Lyons of the U.S. Bankruptcy Court in Trenton, New Jersey gave...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.